TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biognos AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
8
|
0
|
12 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-75
|
-110
|
-116 |
| EBITDA |
-75
|
-109
|
-114 |
| Total assets |
228
|
54
|
52 |
| Current assets |
14
|
54
|
52 |
| Current liabilities |
28
|
38
|
34 |
| Equity capital |
115
|
17
|
18 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
50.4%
|
31.5%
|
34.6% |
| Turnover per employee |
8
|
0
|
12 |
| Profit as a percentage of turnover | -937.5% | -966.7% | |
| Return on assets (ROA) |
-32.9%
|
-203.7%
|
-223.1% |
| Current ratio |
50.0%
|
142.1%
|
152.9% |
| Return on equity (ROE) |
-65.2%
|
-647.1%
|
-644.4% |
| Change turnover |
8
|
-12
|
-76 |
| Change turnover % |
-100%
|
-87% | |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.